Last reviewed · How we verify
NCT04320628
Randomized Double-Blind Controlled Clinical Trial
NA trial testing AnaSept® in Chronic Wounds in 25 participants. Completed in 1 March 2022.
1 February 2022
Quick facts
| Lead sponsor | SerenaGroup, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 20 May 2020 |
| Primary completion | 1 February 2022 |
| Estimated completion | 1 March 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- AnaSept®
- NSS — full drug profile →
Conditions studied
- Chronic Wounds — all drugs for Chronic Wounds →
- Acute Wounds — all drugs for Acute Wounds →
Sponsor
SerenaGroup, Inc. — full company profile →
Who can join
Adults 18 to 100, any sex, with Chronic Wounds or Acute Wounds. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is a randomized double-blind controlled clinical trial designed to compare the ability of NaOCl to NSS in the reduction of bacterial burden in nonhealing acute and chronic wounds.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04320628
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Wounds
Currently open trials in the same condition.
- NCT06424561 — The Influence of Systematic Psychological Intervention on Patients About VSD Drainage Surgery · NA · recruiting
- NCT05172089 — Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence · recruiting
- NCT06939673 — Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care · NA · recruiting
- NCT03793062 — Genetic and Epigenetic Basis of Chronic Wounds · recruiting
Other SerenaGroup, Inc. trials
Trials by the same sponsor.
- NCT05198544 — Clinical Trial Evaluating a Hyaluronic Acid Matrix in the Treatment of Chronic Non-healing Diabetic Foot Ulcers (DFUs) · NA · unknown
- NCT05107050 — Comparing a Synergistic Antimicrobial Cleanser and Gel to Normal Saline and an Amorphous Gel in Reducing Bioburden and P · NA · unknown
- NCT05033470 — A Multicentre Prospective Study Evaluating an Off-loading Mattress Overlay System in Healing of Stage 3 Pressure Ulcers · NA · unknown
- NCT05076578 — A Prospective Clinical Study Evaluating the Harvesting of Micografts · NA · completed
- NCT04888624 — A Comparison Between Two Post-operative Dressings · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04320628 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by SerenaGroup, Inc.
- Last refreshed: 14 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04320628.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing